AU4576501A - Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same - Google Patents

Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same

Info

Publication number
AU4576501A
AU4576501A AU4576501A AU4576501A AU4576501A AU 4576501 A AU4576501 A AU 4576501A AU 4576501 A AU4576501 A AU 4576501A AU 4576501 A AU4576501 A AU 4576501A AU 4576501 A AU4576501 A AU 4576501A
Authority
AU
Australia
Prior art keywords
ifi206
nucleic acids
same
acids encoding
novel interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU4576501A
Inventor
David A Lewin
Sean Adams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
CuraGen Corp
Original Assignee
Genentech Inc
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, CuraGen Corp filed Critical Genentech Inc
Priority claimed from PCT/US2001/008333 external-priority patent/WO2001068830A1/en
Publication of AU4576501A publication Critical patent/AU4576501A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
AU4576501A 2000-03-02 2001-03-13 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same Withdrawn AU4576501A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18651300P 2000-03-02 2000-03-02
PCT/US2001/008333 WO2001068830A1 (en) 2000-03-02 2001-03-13 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same

Publications (1)

Publication Number Publication Date
AU4576501A true AU4576501A (en) 2001-09-24

Family

ID=22685242

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2001245407A Ceased AU2001245407B8 (en) 2000-03-02 2001-03-02 G12L, a gene associated with the thermal response
AU4540701A Pending AU4540701A (en) 2000-03-02 2001-03-02 G12l, a novel gene associated with the thermal response
AU4576501A Withdrawn AU4576501A (en) 2000-03-02 2001-03-13 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AU2001245407A Ceased AU2001245407B8 (en) 2000-03-02 2001-03-02 G12L, a gene associated with the thermal response
AU4540701A Pending AU4540701A (en) 2000-03-02 2001-03-02 G12l, a novel gene associated with the thermal response

Country Status (5)

Country Link
EP (1) EP1268781A2 (en)
JP (1) JP2003525610A (en)
AU (3) AU2001245407B8 (en)
CA (1) CA2401173A1 (en)
WO (1) WO2001064884A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007128553A2 (en) * 2006-05-05 2007-11-15 Dagmar Kratky Mig12

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245526B1 (en) * 1999-05-26 2001-06-12 Incyte Pharmaceuticals, Inc. Lipid metabolism transcription factor
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
EP1242443A4 (en) * 1999-12-23 2005-06-22 Nuvelo Inc Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
JP2003525610A (en) 2003-09-02
AU4540701A (en) 2001-09-12
CA2401173A1 (en) 2001-09-07
WO2001064884A2 (en) 2001-09-07
AU2001245407B2 (en) 2005-07-28
AU2001245407B8 (en) 2005-11-24
EP1268781A2 (en) 2003-01-02
WO2001064884A3 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2002210326A1 (en) A novel polypeptide - human large protein 10.01 and a polynucleotide encoding the same
AU4576501A (en) Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same
EP1282696A4 (en) Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same
AU9538801A (en) A novel polypeptide - human semaphorin protein 9 and a polynucleotide encoding the same
AU2002210340A1 (en) A novel polypeptide- human cbp20 protein 47.74 and the polynucleotide encoding said polypeptide
AU2001231488A1 (en) A novel polypeptide, transducin 18 and the polynucleotide encoding thereof
AU2002210334A1 (en) A novel polypeptide- human notch protein 24.64 and the polynucleotide encoding said polypeptide
AU3910601A (en) A novel polypeptide, an actin 49 and the polynucleotide encoding the polypeptide
AU2002214909A1 (en) A novel polypeptide-homo dna repair protein 10.23 and polynucleotide encoding said polypeptide
AU2001295406A1 (en) A novel polypeptide, a nucleophosmin9.68 and the polynucleotide encoding the polypeptide
AU6891001A (en) A novel polypeptide-kiaa0883-44 and the polynucleotide encoding said polypeptide
AU4630901A (en) A novel polypeptide, helicase-ring-helicase protein 11 and the polynucleotide encoding the polypeptide
AU8950001A (en) A novel polypeptide, dna ligase 21 and the polynucleotide encoding the polypeptide
AU2997101A (en) A new polypeptide-ribosome protein l20,16 and the polynucleotide encoding it
AU2001250244A1 (en) A novel polypeptide, fat24 and the polynucleotide encoding the polypeptide
AU2001273784A1 (en) A novel polypeptide, cdv-1-42 and the polynucleotide encoding the polypeptide
AU6727201A (en) A novel polypeptide - human pax protein 12.5 and the polynucleotide encoding said polypeptide
AU8169101A (en) A novel polypeptide, a ubch5 protein 11.44 and the polynucleotide encoding the polypeptide
AU8953801A (en) A novel polypeptide, a p80-coiline protein 8.8 and the polynucleotide encoding the polypeptide
AU3148901A (en) A novel polypeptide, a transducin 44 and the polynucleotide encoding the polypeptide
AU2002223370A1 (en) A novel polypeptide-human large protein 10.23 and the polynucleotide encoding said polypeptide
AU2002210343A1 (en) A novel polypeptide- human big protein 9.13 and the polynucleotide encoding saidpolypeptide
AU8564601A (en) A new polypeptide-human pax protein 11.9 and the polynucleotide encoding it
AU8564901A (en) A new polypeptide-human pax protein 11.4 and the polynucleotide encoding it
AU2143701A (en) A novel polypeptide, a ribosomal protein s10 14 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND PRIORITY DETAILS TO READ 60/188,716 13 MAR 2000 US

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired